Free shipping on all orders over $ 500

Rubitecan

Cat. No. M20696
Rubitecan Structure
Synonym:

9-NC, 9-Nitro-camptothecin, Partaject Orathecin, Partaject rubitecan, RFS 2000

Size Price Availability Quantity
5mg USD 75  USD75 In stock
10mg USD 100  USD100 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Rubitecan is a topoisomerase I inhibitor extracted from the bark and leaves of the Camptotheca acuminata tree, which is native to China. Rubitecan is an oral camptothecin with antitumour activity.

Chemical Information
Molecular Weight 393.35
Formula C20H15N3O6
CAS Number 91421-42-0
Solubility (25°C) DMSO 58 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Jeffrey W Clark. Expert Opin Investig Drugs. Rubitecan

[2] No authors listed. Drugs R D. Rubitecan: 9-NC, 9-Nitro-20(S)-camptothecin, 9-nitro-camptothecin, 9-nitrocamptothecin, RFS 2000, RFS2000

[3] P M Fracasso, et al. Ann Oncol. Phase I study of rubitecan and gemcitabine in patients with advanced malignancies

[4] Howard Sands, et al. Anticancer Drugs. Preclinical activity of an i.v. formulation of rubitecan in IDD-P against human solid tumor xenografts

[5] Beppino C Giovanella, et al. Int J Oncol. Preclinical evaluation of the anticancer activity and toxicity of 9-nitro-20(S)-camptothecin (Rubitecan)

Related Topoisomerase Products
ICRF-193

ICRF-193 is an TopoII inhibitor.

Topoisomerase II inhibitor 15

Topoisomerase II inhibitor 15 is a Topoisomerase II inhibitor.

Topoisomerase II inhibitor 13

Topoisomerase II inhibitor 13 is a topoisomerase II (Topo II) inhibitor.

ICRF-196

ICRF-196 is an racemic mixture of the (S,S)- and (R,R)-isomers of ICRF-193.

Cholesteryl hemisuccinate

Cholesteryl hemisuccinate is a with hepatoprotective an anticancer activity.

  Catalog
Abmole Inhibitor Catalog




Keywords: Rubitecan, 9-NC, 9-Nitro-camptothecin, Partaject Orathecin, Partaject rubitecan, RFS 2000 supplier, Topoisomerase, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.